FDA panel votes to allow compounding of peptide BPC-157
FDA advisory panel voted to place peptide BPC-157 on a list allowing broader pharmacy compounding, the first of seven peptides under review. The decision supports HHS Secretary RFK Jr.'s push to expand access to these compounds.
·6 sources
